Overview
Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section
Status:
Unknown status
Unknown status
Trial end date:
2015-09-01
2015-09-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Ain Shams Maternity HospitalTreatments:
Tranexamic AcidCriteria
Inclusion Criteria:- - Women undergoing caesarean delivery for various elective indications.
- Full term primiparas / multiparas.
- Singleton pregnancy being delivered by LSCS.
Exclusion Criteria:
- - Medical problems involving the heart, liver, kidney and brain .
- Blood disorders.
- Allergy to tranexamic acid.
- History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia,
uterine anomalies and pathology.
- Multiple pregnancy, macrosomia.
- Polyhydromnios .
- Patients requiring blood transfusion due to anemia